GALECTIN THERAPEUTICS INC (GALT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch GALT
See up to 3 months of GALT. The 7-day demo opens the 1M and 3M ranges and puts GALT on your watchlist.
Start 7-day demoLatest GALT insider trades
About GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC is an SEC registrant, filing under CIK 0001133416, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
GALT Form 4 activity by transaction type, last 90 days
No Form 4 activity for GALT in the last 90 days.
GALT insider transactions (Form 4)
7761 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 1 of 3.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard E. Uihlein - Director | Option exercise | Common Stock | 31,825,235 | $3.00 | $95.48M | |
| Richard E. Uihlein - Director | Option exercise | Common Stock | 2,550,932 | $4.05 | $10.33M | |
| Richard E. Uihlein - Director | Option exercise | Line of Credit Convertible Notes | 0 | $95,475,705.00 footnote F1 | - footnote F1 | |
| Richard E. Uihlein - Director | Option exercise | Line of Credit Convertible Notes | 0 | $10,331,275.00 footnote F2 | - footnote F2 | |
| ||||||
| Khurram Jamil - Officer | Option exercise | Common Stock | 16,250 | $3.04 | $49K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 16,250 | $5.13 footnote F2 | $83K | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 16,250 | $0.00 | - | |
| ||||||
| Harold H. Shlevin | Option exercise | Common Stock | 7,732 | $1.23 | $10K | |
| Harold H. Shlevin | Open-market sale | Common Stock | 7,732 | $5.00 footnote F2 | $39K | |
| Harold H. Shlevin | Option exercise | Common Stock | 22,268 | $1.23 | $27K | |
| Harold H. Shlevin | Open-market sale | Common Stock | 22,268 | $5.04 footnote F4 | $112K | |
| Harold H. Shlevin | Option exercise | Stock Option (right to buy) | 7,732 | $0.00 | - | |
| Harold H. Shlevin | Option exercise | Stock Option (right to buy) | 22,268 | $0.00 | - | |
| ||||||
| Khurram Jamil - Officer | Option exercise | Common Stock | 47,467 | $2.50 | $119K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 47,467 | $5.04 footnote F5 | $239K | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 2,037 | $0.00 | - | |
| Khurram Jamil - Officer | Option exercise | Stock Option (right to buy) | 2,533 | $0.00 | - | |
| Khurram Jamil - Officer | Option exercise | Stock Option (right to buy) | 47,467 | $0.00 | - | |
| Khurram Jamil - Officer | Option exercise | Common Stock | 2,037 | $2.20 | $4K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 2,037 | $5.00 footnote F2 | $10K | |
| Khurram Jamil - Officer | Option exercise | Common Stock | 2,533 | $2.50 | $6K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 2,533 | $5.00 footnote F2 | $13K | |
| ||||||
| Khurram Jamil - Officer | Option exercise | Common Stock | 7,557 | $1.23 | $9K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 7,557 | $3.14 footnote F2 | $24K | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 7,557 | $0.00 | - | |
| ||||||
| Khurram Jamil - Officer | Option exercise | Common Stock | 568 | $1.23 | $699 | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 568 | $3.10 footnote F2 | $2K | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 568 | $0.00 | - | |
| ||||||
| Henry Brem | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Kary Eldred | Open-market purchase | Common Stock | 300 | $2.70 | $810 | |
 Joel Lewis - Officer | Grant or award | Stock option (right to buy) | 91,000 | $0.00 | - | |
| Benjamin Carson Sr. | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Richard A. Zordani Jr. | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Khurram Jamil - Officer | Grant or award | Stock option (right to buy) | 65,000 | $0.00 | - | |
| Khurram Jamil - Officer | Grant or award | Restricted Stock Unit | 100,000 | $0.00 | - | |
| Kevin D. Freeman | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Kary Eldred | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Joel Lewis - Officer | Grant or award | Stock option (right to buy) | 84,000 | $0.00 | - | |
| Joel Lewis - Officer | Grant or award | Restricted Stock Unit | 120,000 | $0.00 | - | |
 Jack W. Callicutt - Officer | Grant or award | Stock option (right to buy) | 65,000 | $0.00 | - | |
| Jack W. Callicutt - Officer | Grant or award | Restricted Stock Unit | 100,000 | $0.00 | - | |
| Harold H. Shlevin | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
 Gilbert S. Omenn | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Gilbert F. Amelio | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Elissa J. Schwartz | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| Richard E. Uihlein | Grant or award | Common Stock | 13,158 footnote F3 | $3.04 footnote F3 | $40K | |
| Richard E. Uihlein | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| ||||||
| Joel Lewis - Officer | Option exercise | Common Stock | 84,000 | $0.00 | - | |
| Joel Lewis - Officer | Open-market sale | Common Stock | 18,571 | $4.20 | $78K | |
| Joel Lewis - Officer | Open-market sale | Common Stock | 27,731 | $3.91 | $108K | |
| Joel Lewis - Officer | Open-market sale | Common Stock | 37,698 | $3.58 | $135K | |
| Joel Lewis - Officer | Option exercise | Restricted Stock Unit | 84,000 | $0.00 | - | |
| Jack W. Callicutt - Officer | Option exercise | Common Stock | 60,000 | $0.00 | - | |
| Jack W. Callicutt - Officer | Open-market sale | Common Stock | 13,914 | $4.20 | $58K | |
| Jack W. Callicutt - Officer | Open-market sale | Common Stock | 25,732 | $3.90 | $100K | |
| Jack W. Callicutt - Officer | Open-market sale | Common Stock | 20,354 | $3.67 | $75K | |
| Jack W. Callicutt - Officer | Option exercise | Restricted Stock Unit | 60,000 | $0.00 | - | |
| Khurram Jamil - Officer | Option exercise | Common Stock | 60,000 | $0.00 | - | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 13,055 | $4.20 | $55K | |
| Khurram Jamil - Officer | Open-market sale | Common stock | 25,499 | $3.90 | $99K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 21,446 | $3.65 | $78K | |
| Khurram Jamil - Officer | Option exercise | Restricted Stock Unit | 60,000 | $0.00 | - | |
| Khurram Jamil - Officer | Option exercise | Common Stock | 8,125 | $1.23 | $10K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 8,125 | $4.07 | $33K | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 8,125 | $0.00 | - | |
| Kevin D. Freeman | Open-market purchase | Common Stock | 5,500 | $3.55 | $20K | |
| Kary Eldred | Open-market purchase | Common Stock | 700 | $3.73 | $3K | |
| Joel Lewis - Officer | Option exercise | Common Stock | 7,829 | $2.86 | $22K | |
| Joel Lewis - Officer | Open-market sale | Common Stock | 7,829 | $7.06 footnote F4 | $55K | |
| Joel Lewis - Officer | Option exercise | Stock option (right to buy) | 7,829 | $0.00 | - | |
| ||||||
| Khurram Jamil - Officer | Open-market sale | Common Stock | 4,479 | $7.04 footnote F2 | $32K | |
| Khurram Jamil - Officer | Option exercise | Common Stock | 6,463 | $2.20 | $14K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 6,463 | $7.04 footnote F2 | $45K | |
| Khurram Jamil - Officer | Option exercise | Common Stock | 8,500 | $2.50 | $21K | |
| Khurram Jamil - Officer | Open-market sale | Common Stock | 8,500 | $7.04 footnote F2 | $60K | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 6,463 | $0.00 | - | |
| Khurram Jamil - Officer | Option exercise | Stock option (right to buy) | 8,500 | $0.00 | - | |
| ||||||
Item 2.02, 9.01
Item 3.02, 9.01
Item 7.01, 9.01
Item 2.02, 9.01
Recent GALT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
GALT insider trading FAQ
What is the latest insider trade for GALT?
GALECTIN THERAPEUTICS INC (GALT) has filed no insider reports in the last 90 days. The most recent on record is dated 4 August 2026. The full record for GALT runs to 61 Form 4 filings, the earliest from 16 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GALT stock?
No insider purchases of GALT were filed in the last 90 days. 13 purchases are on record for this company.
How many insiders are selling GALT stock?
No insider sales of GALT were filed in the last 90 days. 66 sales are on record for this company.
Where can I see GALT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GALT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Richard E. Uihlein view on EDGAR
- - Khurram Jamil view on EDGAR
- - Harold H. Shlevin view on EDGAR
- - Khurram Jamil view on EDGAR
- - Khurram Jamil view on EDGAR
- - Khurram Jamil view on EDGAR
- - Henry Brem view on EDGAR
- - Kary Eldred view on EDGAR
- - Joel Lewis view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where GALT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GALT with a 7-day demo
- GALT on your watchlist
- Every GALT Form 4 filing on record
- Up to 3 months of GALT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
